17. Closer look: Radiotherapy
• Can damage normal cells
• Different cancer types have different radiosensitivity
• High (leukemia, lymphoma, ovarian/testicular), ~30 Gy
• Moderate (breast, prostate, lung, colon), ~70 Gy
• Low (skin, kidney), too high to be safe
• Curability is usually reverse of radiosensitivity
• Therefore usually requires chemotherapy
• Intensity vs exposure constraint
18. Advances in Radiotherapy
• Advanced image guiding systems – higher precision
• SABR (stereotactic ablative body radiation)
• Synchrotron MRT (microbeam radiotherapy)
• Pre-clinical testing due to unknown reason for low local tissue
sensitivity
20. Synchrotron MRT
• High flux X-rays segmented into a lattice of micro-planar
beams separated by plains of low dose radiation, allowing very
high doses (over 100 Gy) of radiation
22. Closer Look: Immunotherapy
• Mechanism: body’s immune system will fight cancer cells
• Three “E”’s of immunoediting
• Elimination
• Equilibrium
• Escape
• Limited to cancer cells which release high immunoactivators
• Cancer cells which release little/no immunoactivators are not
affected
23. Elimination
• Cancer cells release immunoactivators which act as receptors
for white blood cells to target
25. Escape
• New cancer cell variants continue to attack the body without
resistance from immune system
26. Combining Radiotherapy and
Immunotherapy
• Positive Effects (2-15 Gy)
• Irradiated cancer cells are a good source of diverse
immunoactivators
• Radiation activates MHC class I receptors in cancer cells, releasing
more immunoactivators
• New immunoactivators are memorized and used for secondary
cancers
• Negative Effects (Over 15 Gy)
• Cancer cells enters “wound healing” state when dosage is too
high, releasing immunosupressant chemicals
• Immunosupressant chemicals prevent/inhibit release of
immunoactivators such has MHC class I receptors
28. Conclusion
• Radiotherapy has become more precise due to technological
advancement
• Immunotherapy is limited to cancer cells which release
enough immunoactivators
• Radiotherapy can allow utilization of irradiated cancer cells in
immunotherapy to increase effectiveness, with low radiation
doses more effective in this case